Taxanes combined with Apatinib mesylate in the treatment for patients with advanced breast cancer: an open-label, single-arm, single-center clinical research
Latest Information Update: 12 Oct 2016
At a glance
- Drugs Rivoceranib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 12 Oct 2016 New trial record